Literature DB >> 2413037

Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin.

J van der Meer, E G de Vries, R Vriesendorp, P H Willemse, A J Donker, J G Aalders.   

Abstract

A 23-year-old woman with metastatic Sertoli-Leydig cell tumor was treated with cisplatin, vinblastine, and bleomycin. Hemolytic uremic syndrome appeared, while no evidence of residual tumor was found. Infusion of fresh frozen plasma together with aspirin and dipyridamole resulted in recovery of microangiopathic hemolytic anemia and thrombocytopenia. Renal insufficiency, however, persisted.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413037     DOI: 10.1007/bf00402723

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

Review 1.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

2.  Coronary artery disease after treatment with bleomycin and vinblastine.

Authors:  N J Vogelzang; D H Frenning; B J Kennedy
Journal:  Cancer Treat Rep       Date:  1980 Oct-Nov

Review 3.  Thrombotic thrombocytopenic purpura: a review.

Authors:  R M Bukowski
Journal:  Prog Hemost Thromb       Date:  1982

4.  Raynaud's phenomenon after bleomycin treatment.

Authors:  D P Chernicoff; R M Bukowski; J R Young
Journal:  Cancer Treat Rep       Date:  1978-04

5.  Microangiopathic hemolytic anemia and cancer: a review.

Authors:  K H Antman; A T Skarin; R J Mayer; H K Hargreaves; G P Canellos
Journal:  Medicine (Baltimore)       Date:  1979-09       Impact factor: 1.889

6.  Renal disease after mitomycin C therapy.

Authors:  W T Hanna; S Krauss; R F Regester; W M Murphy
Journal:  Cancer       Date:  1981-12-15       Impact factor: 6.860

7.  Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma.

Authors:  B R Kressel; K P Ryan; A T Duong; J Berenberg; P S Schein
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

8.  Treatment of the hemolytic uremic syndrome with plasma.

Authors:  G Remuzzi; R Misiani; D Marchesi; M Livio; G Mecca; G de Gaetano; M D Donati
Journal:  Clin Nephrol       Date:  1979-12       Impact factor: 0.975

Review 9.  Mitomycin-associated renal failure. Case report and review.

Authors:  R W Hamner; R Verani; E J Weinman
Journal:  Arch Intern Med       Date:  1983-04

10.  The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

View more
  1 in total

Review 1.  Anticancer drug-induced kidney disorders.

Authors:  P E Kintzel
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.